---
title: "Black Hawk appoints Michael Tolentino as Vesicor CEO; Luo Feng becomes Chief Scientific Officer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279494629.md"
description: "Black Hawk has appointed Michael Tolentino as the new CEO of Vesicor, effective March 17, 2026, replacing Luo Feng, who will transition to the role of Chief Scientific Officer on the same date. Tolentino is a seasoned entrepreneur and retinal surgeon with over 20 years of experience in biotech, including significant contributions to the development of Avastin. The changes are part of an employment agreement as stated in the SEC filing."
datetime: "2026-03-17T21:33:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279494629.md)
  - [en](https://longbridge.com/en/news/279494629.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279494629.md)
---

# Black Hawk appoints Michael Tolentino as Vesicor CEO; Luo Feng becomes Chief Scientific Officer

**Black Hawk appointed Michael Tolentino as CEO of Vesicor, effective March 17, 2026, while Luo Feng moved from CEO to Chief Scientific Officer the same day.**

Individual

Michael Tolentino

Luo Feng

Role

Chief Executive Officer of Vesicor Therapeutics

Chief Scientific Officer of Vesicor Therapeutics

Type of Change

Appointed

Assumed new role

Effective Date

March 17, 2026

March 17, 2026

Reason

Employment Agreement signed; appointment to lead Vesicor (as stated in filing)

Former CEO assumed Chief Scientific Officer role (as stated in filing)

Replacement Info

Replaced Luo Feng as CEO

Replaced as CEO by Michael Tolentino

Background Details

Serial entrepreneur and retinal surgeon with 20+ years in biotech; involvement in Avastin development; founder/CEO/CSO/CMO roles at prior companies (summary from filing)

Not disclosed

Board/Committee Role Changes

Not disclosed

Not disclosed

Original SEC Filing: Black Hawk Acquisition Corp \[ BKHA \] - 8-K - Mar. 17, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BKHA.US](https://longbridge.com/en/quote/BKHA.US.md)

## Related News & Research

- [Simeon George Discloses Investment at Odyssey Therapeutics with 8.0% Stake](https://longbridge.com/en/news/286825924.md)
- [Amgen Announces CFO Transition and Leadership Succession Plan](https://longbridge.com/en/news/286964358.md)
- [Vericel Corporation $VCEL Stock Position Reduced by Truist Financial Corp](https://longbridge.com/en/news/286758697.md)
- [Greenland Mines delays quarterly SEC filing](https://longbridge.com/en/news/286596535.md)
- [Zenas BioPharma Insider Bought Shares Worth $1,012,800, According to a Recent SEC Filing](https://longbridge.com/en/news/286872009.md)